Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Revenue (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Revenue for 16 consecutive years, with $33.8 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 16.19% to $33.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $129.4 million through Dec 2025, up 29.95% year-over-year, with the annual reading at $129.4 million for FY2025, 29.95% up from the prior year.
  • Revenue for Q4 2025 was $33.8 million at Niagen Bioscience, roughly flat from $34.0 million in the prior quarter.
  • The five-year high for Revenue was $34.0 million in Q3 2025, with the low at $14.7 million in Q1 2021.
  • Average Revenue over 5 years is $22.6 million, with a median of $21.1 million recorded in 2022.
  • The sharpest move saw Revenue dropped 5.46% in 2022, then skyrocketed 37.59% in 2025.
  • Over 5 years, Revenue stood at $17.8 million in 2021, then increased by 18.23% to $21.0 million in 2022, then grew by 0.95% to $21.2 million in 2023, then soared by 37.41% to $29.1 million in 2024, then rose by 16.19% to $33.8 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $33.8 million, $34.0 million, and $31.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.